CRISPR and Cas Genes

Global CRISPR and Cas Genes Market to Reach US$13.2 Billion by 2030

The global market for CRISPR and Cas Genes estimated at US$5.1 Billion in the year 2024, is expected to reach US$13.2 Billion by 2030, growing at a CAGR of 17.4% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 19.0% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Libraries segment is estimated at 18.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 16.3% CAGR

The CRISPR and Cas Genes market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 16.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global CRISPR and Cas Genes Market – Key Trends & Drivers Summarized

Why Is CRISPR Technology Revolutionizing Biotechnology? Exploring the Rise of Gene Editing

The global CRISPR and Cas genes market has seen exponential growth, driven by groundbreaking advancements in genetic engineering, biomedical research, and agricultural biotechnology. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has emerged as a game-changing tool, enabling precise gene editing with unprecedented accuracy and efficiency. The increasing focus on gene therapy for treating genetic disorders, cancer, and rare diseases has propelled investment in CRISPR-based applications. Additionally, agricultural biotechnology firms are leveraging CRISPR for crop improvement, disease resistance, and enhanced food production efficiency. The expanding field of synthetic biology and the development of personalized medicine have further strengthened market demand, with CRISPR playing a crucial role in targeted genetic modifications.

Which CRISPR Applications Are Leading the Market? A Breakdown of Key Segments

The CRISPR and Cas genes market is segmented into various applications, each catering to specific scientific and medical advancements. Gene therapy remains one of the most promising applications, with CRISPR being used to correct genetic mutations responsible for inherited disorders such as sickle cell anemia and cystic fibrosis. Agricultural biotechnology is another key segment, where CRISPR is revolutionizing crop development by enhancing drought resistance, disease tolerance, and nutritional content. The rise of CRISPR-based diagnostics has also gained traction, particularly in detecting infectious diseases, including COVID-19. Additionally, the field of drug discovery is benefiting from CRISPR’s ability to create genetically engineered cell models, improving pharmaceutical research and development. The development of CRISPR-based biomanufacturing solutions for synthetic biology and industrial applications has further diversified market opportunities.

How Is Innovation Driving the CRISPR Market? The Role of AI, Automation & Ethical Considerations

The CRISPR market is evolving rapidly with continuous innovations in AI-powered gene editing, automation in genetic screening, and ethical advancements in genome modification. AI-driven bioinformatics tools have enhanced CRISPR efficiency, enabling researchers to predict off-target effects and optimize gene-editing accuracy. The development of next-generation Cas proteins, such as Cas12 and Cas13, has expanded CRISPR’s versatility, allowing for RNA-based modifications and improved specificity. Additionally, the automation of CRISPR workflows through robotic lab systems has accelerated research productivity, reducing manual intervention and increasing throughput. Ethical considerations surrounding gene editing, particularly in human germline modifications, have prompted regulatory frameworks and bioethical discussions to ensure responsible research practices. The emergence of CRISPR-based epigenetic editing, which modifies gene expression without altering DNA sequences, has opened new possibilities for treating complex diseases.

What’s Driving the Growth of the CRISPR Market? Key Market Influencers Explained

The growth in the CRISPR and Cas genes market is driven by increasing investment in genetic research, expanding applications in medicine and agriculture, and continuous technological advancements. The rise of precision medicine has fueled demand for CRISPR-based therapies, offering personalized treatment solutions for genetic disorders and cancer. Additionally, government funding and academic research initiatives have accelerated innovation in CRISPR-based drug discovery and disease modeling. The agricultural sector’s growing need for climate-resilient crops has further boosted CRISPR adoption, providing sustainable solutions for food security challenges. The expansion of biotech startups and partnerships between pharmaceutical companies and research institutions has strengthened market competitiveness. However, ethical and regulatory considerations remain a critical factor, influencing the pace of CRISPR commercialization. With ongoing scientific breakthroughs and evolving regulatory landscapes, the global CRISPR and Cas genes market is expected to witness transformative growth, unlocking new possibilities in genetic engineering and personalized healthcare.

SCOPE OF STUDY:

The report analyzes the CRISPR and Cas Genes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product & Service (Kits & Reagents, Libraries, Design Tool, Antibodies, Cell Line Engineering, gRNA Design & Synthesis & Synthesis, Screening Services); Application (Biomedical Application, Agricultural Application); End-Use (Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use, Contract Research Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

• Addgene
• Agilent Technologies
• Beam Therapeutics
• Caribou Biosciences
• Cellectis
• CRISPR Therapeutics
• Editas Medicine
• GenScript
• Horizon Discovery (PerkinElmer)
• Integrated DNA Technologies (IDT)
• Intellia Therapeutics
• Locus Biosciences
• Mammoth Biosciences
• Merck KGaA
• New England Biolabs
• Origene Technologies
• Sangamo Therapeutics
• Synthego Corporation
• Takara Bio Inc.
• Thermo Fisher Scientific

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.